We are testing a new treatment called OT-A201 in patients with certain blood cancers and solid tumors. This study aims to understand its safety and effectiveness in humans.
Health conditions and diseases that the clinical trial is designed to study and treat.
Relapsed or refractory hematological malignancies are types of blood cancers that return after treatment or do not respond to treatment. Advanced or metastatic solid tumors refer to cancers that have spread beyond their original site. Both conditions can lead to serious health issues and require specialized treatment.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.